Stay updated on VX-880 in Type 1 Diabetes: Safety Clinical Trial
Sign up to get notified when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.

Latest updates to the VX-880 in Type 1 Diabetes: Safety Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 banner appears; the old Revision: v3.4.1 notice and the government funding lapse notice were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedThe top of the page now displays a government funding lapse notice and the site revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedThese changes are minor UI/text updates and a revision marker that do not affect core study content; they include a new 'Show glossary' option, capitalization tweaks for QC-related labels, and a revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4, with no impact on the study's details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedNew locations were added to the study's Locations section, including sites in California, Florida, Illinois, Maryland, Massachusetts, Pennsylvania, Texas, Virginia, Wisconsin, and Oxford. The revision version was updated to v3.3.3 and some previously listed locations were removed.SummaryDifference1%

Stay in the know with updates to VX-880 in Type 1 Diabetes: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.